4880 CellSource Co.,Ltd.セルソースTSE Standard / Pharmaceuticals
0 posts
CellSource Co.,Ltd. (4880) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
CellSource Co.,Ltd. (4880) Stock Price HistoryNear an all-time low
CellSource Co.,Ltd. closed at ¥262 on Nov 20, 2026, −16.0% over 1 month, −48.3% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥83,974 today (−16.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −16.0%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥262 | −8 | −2.96% |
| Nov 18 (Wed) | ¥270 | −2 | −0.74% |
| Nov 17 (Tue) | ¥272 | −6 | −2.16% |
| Nov 16 (Mon) | ¥278 | −4 | −1.42% |
| Nov 13 (Fri) | ¥282 | +1 | +0.36% |
| Nov 12 (Thu) | ¥281 | +0 | +0.00% |
| Nov 11 (Wed) | ¥281 | −5 | −1.75% |
| Nov 10 (Tue) | ¥286 | +5 | +1.78% |
| Nov 9 (Mon) | ¥281 | +10 | +3.69% |
| Nov 6 (Fri) | ¥271 | −19 | −6.55% |
If you had invested ¥100,000 3 months ago, it would be worth ¥74,644 today (−25.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −25.4%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥262 | −8 | −2.96% |
| Nov 18 (Wed) | ¥270 | −2 | −0.74% |
| Nov 17 (Tue) | ¥272 | −6 | −2.16% |
| Nov 16 (Mon) | ¥278 | −4 | −1.42% |
| Nov 13 (Fri) | ¥282 | +1 | +0.36% |
| Nov 12 (Thu) | ¥281 | +0 | +0.00% |
| Nov 11 (Wed) | ¥281 | −5 | −1.75% |
| Nov 10 (Tue) | ¥286 | +5 | +1.78% |
| Nov 9 (Mon) | ¥281 | +10 | +3.69% |
| Nov 6 (Fri) | ¥271 | −19 | −6.55% |
If you had invested ¥100,000 6 months ago, it would be worth ¥75,504 today (−24.5%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −24.5%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥262 | −8.4% |
| Oct 2026 | ¥286 | −8.3% |
| Sep 2026 | ¥312 | −12.6% |
| Aug 2026 | ¥357 | +10.9% |
| Jul 2026 | ¥322 | +3.2% |
| Jun 2026 | ¥312 | −10.3% |
| May 2026 | ¥348 | −5.2% |
If you had invested ¥100,000 1 year ago, it would be worth ¥51,677 today (−48.3%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved −48.3%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥262 | −8.4% |
| Oct 2026 | ¥286 | −8.3% |
| Sep 2026 | ¥312 | −12.6% |
| Aug 2026 | ¥357 | +10.9% |
| Jul 2026 | ¥322 | +3.2% |
| Jun 2026 | ¥312 | −10.3% |
| May 2026 | ¥348 | −5.2% |
| Apr 2026 | ¥367 | −1.3% |
| Mar 2026 | ¥372 | −12.1% |
| Feb 2026 | ¥423 | +5.0% |
| Jan 2026 | ¥403 | +1.0% |
| Dec 2025 | ¥399 | −22.8% |
| Nov 2025 | ¥517 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥16,123 today (−83.9%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved −83.9%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥262 | −34.3% |
| 2025 | ¥399 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥3,819 today (−96.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved −96.2%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥262 | −34.3% |
| 2025 | ¥399 | ― |
If you had invested ¥100,000 in Oct 2019, it would be worth ¥26,826 today (−73.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +138.6%, while this stock moved −73.2%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥262 | −34.3% |
| 2025 | ¥399 | −52.0% |
| 2024 | ¥832 | −34.9% |
| 2023 | ¥1,279 | −68.1% |
| 2022 | ¥4,005 | −26.2% |
| 2021 | ¥5,430 | +50.0% |
| 2020 | ¥3,620 | +188.3% |
| 2019 | ¥1,256 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Oct 2019). Please check the latest prices before trading.
CellSource Co.,Ltd. (4880) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of CellSource Co.,Ltd. (4880)
Business overview
The company was founded in November 2015 to industrialize regenerative medicine. For medical institutions that provide regenerative medicine, it offers contract processing and storage of tissues and cells derived from blood and fat, support services for regulatory compliance and management under Japan's regenerative medicine laws, medical device sales and cosmetics sales. In its blood-derived processing service, it makes platelet-rich plasma (PRP) from blood that medical institutions collect from patients, then concentrates growth factors and freeze-dries it into PFC-FD. Medical institutions use this in self-paid treatments, mainly for knee osteoarthritis and infertility.
Summarized from the annual securities report (fiscal year ended October 2025) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| PBR | 0.87x | Below the sector median of 1.86x (No. 17 from the lowest) |
|---|---|---|
| ROE | -2.09% | No. 36 in the sector (highest first); median 4.17% |
| Market cap | ¥5.2 bn | No. 63 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥517 | 2025/11/28 |
|---|---|---|
| 52-week low | ¥262 | 11/20 |
| Current position | 0.0% | Where the low is 0% and the high is 100% (close on 11/20: ¥262) |
| Year to date | -34.3% | No. 57 of 77 in the sector (best first) |
| 1 year | -48.3% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/11 15:30加工受託サービス事業に係る月次KPI速報の開示終了に関するお知らせ
- 11/11 15:302026年10月期10月度月次KPI速報
- 10/13 15:30棚卸資産評価損及び特別損失の計上(見込み)に関するお知らせ
- 10/09 15:302026年10月期9月度月次KPI速報
- 09/09 15:30主要株主である筆頭株主及び主要株主並びにその他の関係会社の異動(予定)並びに公開買付けに準ずる行為として政令で定める買集め行為に関するお知らせ
- 09/08 15:302026年10月期第3四半期決算短信〔日本基準〕(非連結)
- 09/08 15:30業績予想の修正に関するお知らせ
- 09/08 15:30本店移転及び特別損失の計上(見込み)に関するお知らせ
Filings from the past 12 months (8).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the CellSource Co.,Ltd. board
More Japanese stocks in English
- FunPep Company Limited4881
- Perseus Proteomics Inc.4882
- Modalis Therapeutics Corporation4883
- Kringle Pharma,Inc.4884
- MUROMACHI CHEMICALS INC.4885
- ASKA Pharmaceutical Holdings Co.,Ltd.4886
- SAWAI GROUP HOLDINGS Co.,Ltd.4887
- STELLA PHARMA CORPORATION4888
- Renascience Inc.4889
- iShares Yen Appreciation Focus ETF488A
- Tsubota Laboratory Incorporated4890
- TMS Co.,Ltd.4891